Phase II study of erlotinib (OSI 774) in women with recurrent or metastatic endometrial cancer: NCICCTG IND-148. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Jasas, KV
  • Fyles, A
  • Elit, Laurie
  • Hoskins, PJ
  • Biagi, J
  • Dubuc-Lissoir, J
  • Matthews, S
  • Dancey, J
  • Eisenhauer, E
  • Oza, AM

publication date

  • July 15, 2004